CNTO surprised by GNE infringment suit

CNTO surprised by GNE infringment suit Centocor Inc. will likely try to negotiate with Genentech Inc. regarding a license for CNTO's CentoRx gpIIb/IIIa platelet inhibitor, rather than see a suit filed by GNE go to trial.

GNE last week said it sued CNTO in the U.S.

Read the full 594 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE